Create your single-domain antibody in 6 weeks effortlessly with our unique EVOBodies™ program. This is our promise. At IMMUNOCHEM we believe that you shouldn’t struggle to generate antigen-binding molecules as starting materials for your crucial research. Through the EVOBodies™ platform, IMMUNOCHEM provides precise AI-driven antibody discovery, helping bio-pharmaceutical managers and scientists : 👉 save time 👉 reduce stress 👉 achieve the groundbreaking research results they deserve. Today, by combining AI and biological tools, you have the power in your hand to create your tailored antibodies in only a few weeks. Rather than waiting months for unpredictable results from traditional immunization processes. What's even better? This method works for any antigen, including : 🎯 little or non-immunogenic 🎯 toxic for the host 🎯 highly conserved 🎯 targeting vital functions 💫 Follow our Linkedin page and let's embark on this groundbreaking adventure together.
| Website | https://www.immunochem.be/ |
| Employees | 4 (4 on RocketReach) |
| Founded | 1998 |
| Industry | Biotechnology Research |
| Keywords | Antibody Engineering, Antibody Production, Antibody Discovery, Custom Antibody Services, Therapeutic Antibodies, Biotechnology, Drug Discovery, Molecular Biology, Protein Engineering, Immunology Research, Pharmaceutical Development, Biopharmaceutical |
Looking for a particular Immunochem employee's phone or email?
Philippe Herman is the CEO of Immunochem.
4 people are employed at Immunochem.